ERBB2 and breast carcinoma: As [68Ga]Ga-NOTA-anti-HER2-sdAb uptake is seen even in lesions with a low immunohistochemistry score, this tracer might help to assess the disease extent in breast carcinoma with lower [18F]FDG avidity.